David Bronner is spearheading a sit-in at DEA headquarters next month to demand access to psilocybin for patients under the federal “Right to Try” law.
Patients who were denied end-of-life psychedelic therapy by the DEA turn to Senator Patty Murray to intervene with the federal agency.
The bills would create a state-funded research institute, decriminalize magic mushrooms, and provide psilocybin-assisted therapy for eligible patients.
California’s pending psychedelic decrim bill SB 519 is being held in the state legislature to give the coalition behind the legislation time to build support.
New York and Washington consider bills to legalize the medical use of psilocybin, while Colorado voters might establish medical frameworks for psilocybin therapy this November.
Concerned scientists say that the proposal will inevitably hamper vital research of nearly 100 related compounds.
Canada has loosened restrictions for doctors to use MDMA and psilocybin to treatment-resistant conditions and terminally ill patients, but the approval process is slower than some patients can afford.
Pioneering research into psilocybin for treating veterans with PTSD has made Republicans like Rick Perry unlikely allies with Democrats in the Texas legislature.
On Tuesday, Detroit citizens passed a ballot that makes plant-based psychedelics the lowest priority for law enforcement.